Zobrazeno 1 - 6
of 6
pro vyhledávání: '"I. P. Dorfman"'
Publikováno v:
Эпидемиология и вакцинопрофилактика, Vol 21, Iss 5, Pp 89-97 (2022)
Relevance. Pneumococcal infection (PI) is one of the leading causes of disability and death of older people worldwide. In the Astrakhan region, as in other regions of the Russian Federation, there is a low coverage of pneumococcal vaccination (PV) an
Externí odkaz:
https://doaj.org/article/6f5073ac0e0941f4912e8a5a0fd5d685
Publikováno v:
Фармация и фармакология (Пятигорск), Vol 10, Iss 2, Pp 187-197 (2022)
The aim of the article is the evaluation of the economic damage (ED) because of the absence of pneumococcal vaccination as a leading risk factor for the development of community-acquired pneumonia (CAP) and acute exacerbations of а chronic obstructi
Externí odkaz:
https://doaj.org/article/4c8f2c0ec18d48e7bc79750a61a8580a
Publikováno v:
Медицинский совет, Vol 0, Iss 4, Pp 128-137 (2022)
A literature review presents the efficacy and safety of the new glycopyrronium bromide/formoterol fumarate (GP/FF) combination in the treatment of patients with chronic obstructive pulmonary disease according to the PINNACLE 1, 2, 3, 4 studies. There
Externí odkaz:
https://doaj.org/article/94fa093ebf164e40a945a546c37eeea4
Publikováno v:
Фармация и фармакология (Пятигорск), Vol 9, Iss 2, Pp 130-138 (2021)
The aim of the study was to estimate the economic damage by COPD, including direct medical and non-medical costs and indirect costs associated with premature deaths of working-age individuals.Materials and methods. First, estimation of the economic C
Externí odkaz:
https://doaj.org/article/9b26dda177d642438a68af206da01761
Publikováno v:
Фармация и фармакология (Пятигорск), Vol 8, Iss 6, Pp 436-445 (2021)
The aim. To evaluate the economic efficiency and the choice of the vaccination strategy in the respiratory pneumococcal infection risk groups among the adult population of the Astrakhan region.Materials and methods. The data for the period of 2015 -
Externí odkaz:
https://doaj.org/article/b8e2c150c717434da3b5d42fd166da30
Publikováno v:
PULMONOLOGIYA. 31:518-529
The choice of drugs used to treat patients with chronic obstructive pulmonary disease (COPD) (inhaled β-agonists, M-anticholinergic drugs, inhaled corticosteroids (ICS)) in view of their interchangeability is reviewed in this article. This aspect is